Agile Therapeutics, Inc.

OTCPK:AGRX Stok Raporu

Piyasa değeri: US$10.4m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Agile Therapeutics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Agile Therapeutics has a total shareholder equity of $-21.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.0M and $36.9M respectively.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranın/a
NakitUS$2.85m
Eşitlik-US$21.91m
Toplam yükümlülüklerUS$36.88m
Toplam varlıklarUS$14.96m

Son finansal sağlık güncellemeleri

Recent updates

Agile appoints chief commercial officer from within ranks amid leadership revamp

Oct 10

Agile gains as H.C. Wainwright sees 630% upside potential

Jul 11

Agile Therapeutics prices $24M upsized stock offering

Jul 01

Agile Therapeutics: Twirla's Lackluster Launch Forces Me To Change My Strategy

Apr 04

Agile Therapeutics: Bullish On Capitulation And Max Pain

Oct 19

Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy

Jul 30

Agile Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 06

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Feb 25
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?

Agile Therapeutics issues cash projection at JP Morgan healthcare conference

Jan 14

Assessing Agile Therapeutics

Jan 10

How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Jan 04
How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?

Agile Therapeutics announces peer-reviewed publication of late-stage study for Twirla contraception patch

Nov 30

Agile Therapeutics EPS in-line

Nov 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AGRX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: AGRX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AGRX is debt free.

Borcun Azaltılması: AGRX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: AGRX has sufficient cash runway for more than a year based on its current free cash flow.

Tahmini Nakit Akışı: AGRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 2.1% each year


Sağlıklı şirketleri keşfedin